STOCK TITAN

Aktis Oncology: T. Rowe Price reports 6.2% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Aktis Oncology, Inc. (AKTS) shares were the subject of an ownership report by T. Rowe Price Investment Management, Inc., which reported beneficial ownership of 3,333,026 shares, or 6.2% of the class, as of September 30, 2026. It reported sole voting and sole dispositive power over 3,333,026 shares, with no shared voting or dispositive power. The investment manager expressly denied that the report should be construed as an admission that it is the beneficial owner of the securities.

Reported beneficial ownership 3,333,026 shares Reported by T. Rowe Price Investment Management, Inc. as of September 30, 2026
Percent of class 6.2% Reported by T. Rowe Price Investment Management, Inc.
Sole voting power 3,333,026 shares Reported by T. Rowe Price Investment Management, Inc.
Sole dispositive power 3,333,026 shares Reported by T. Rowe Price Investment Management, Inc.
beneficial owner financial
"expressly denied that it is the beneficial owner"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
sole voting power financial
"Sole Voting Power 3,333,026.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power financial
"Sole Dispositive Power 3,333,026.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AKTS shares did T. Rowe Price Investment Management report?

T. Rowe Price Investment Management, Inc. reported 3,333,026 Aktis Oncology shares, representing 6.2% of the class, with sole voting and dispositive power over that amount; it expressly denied that the report was an admission of beneficial ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





01021M104

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



T. Rowe Price Investment Management, Inc.
Signature:Ellen York
Name/Title:Vice President
Date:11/16/2026

Keep reading